Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504, Coimbra, Portugal.
Institute for Interdisciplinary Research (IIIUC), University of Coimbra, 3030-789, Coimbra, Portugal.
BMC Microbiol. 2019 Mar 19;19(1):62. doi: 10.1186/s12866-019-1428-4.
Nontuberculous mycobacteria (NTM) are ubiquitous in nature and recognized agents of opportunistic infection, which is often aggravated by their intrinsic resistance to antimicrobials, poorly defined therapeutic strategies and by the lack of new drugs. However, evaluation of their prevalence in anthropogenic environments and the associated antimicrobial resistance profiles have been neglected. In this work, we sought to determine minimal inhibitory concentrations of 25 antimicrobials against 5 NTM isolates recovered from a tertiary-care hospital surfaces. Antimicrobial susceptibilities of 5 other Corynebacterineae isolated from the same hospital were also determined for their potential clinical relevance.
Our phylogenetic study with each of the NTM isolates confirm they belong to Mycobacterium obuense, Mycobacterium mucogenicum and Mycobacterium paragordonae species, the latter initially misidentified as strains of M. gordonae, a species frequently isolated from patients with NTM disease in Portugal. In contrast to other strains, the M. obuense and M. mucogenicum examined here were resistant to several of the CLSI-recommended drugs, suggestive of multidrug-resistant profiles. Surprisingly, M. obuense was susceptible to vancomycin. Their genomes were sequenced allowing detection of gene erm (erythromycin resistance methylase) in M. obuense, explaining its resistance to clarithromycin. Remarkably, and unlike other strains of the genus, the Corynebacterium isolates were highly resistant to penicillin, ciprofloxacin and linezolid.
This study highlights the importance of implementing effective measures to screen, accurately identify and control viable NTM and closely related bacteria in hospital settings. Our report on the occurrence of rare NTM species with antibiotic susceptibility profiles that are distinct from those of the corresponding Type strains, along with unexpected resistance mechanisms detected seem to suggest that resistance may be more common than previously thought and also a potential threat to frail and otherwise vulnerable inpatients.
非结核分枝杆菌(NTM)广泛存在于自然界中,是机会性感染的病原体,由于其对抗生素的固有耐药性、治疗策略不明确以及缺乏新药,感染往往会加重。然而,它们在人为环境中的流行情况及其相关的抗生素耐药谱的评估尚未得到重视。在这项工作中,我们试图确定从一家三级保健医院表面分离的 5 株 NTM 分离株对 25 种抗生素的最小抑菌浓度。还确定了从同一医院分离的 5 株其他棒状杆菌的药敏性,以评估其潜在的临床相关性。
我们对每一株 NTM 分离株进行的系统发育研究证实,它们属于 Mycobacterium obuense、Mycobacterium mucogenicum 和 Mycobacterium paragordonae 种,后者最初被错误地鉴定为 M. gordonae 菌株,该种经常从葡萄牙患有 NTM 疾病的患者中分离出来。与其他菌株不同,这里检查的 M. obuense 和 M. mucogenicum 对几种 CLSI 推荐的药物耐药,提示存在多药耐药谱。令人惊讶的是,M. obuense 对万古霉素敏感。对它们的基因组进行测序,发现 M. obuense 中存在 erm(红霉素耐药甲基化酶)基因,解释了其对克拉霉素的耐药性。值得注意的是,与该属的其他菌株不同,棒状杆菌分离株对青霉素、环丙沙星和利奈唑胺高度耐药。
本研究强调了在医院环境中实施有效措施筛选、准确识别和控制活的 NTM 和密切相关细菌的重要性。我们报告了罕见的 NTM 种的发生,其抗生素敏感性谱与相应的模式菌株不同,以及检测到的意外耐药机制似乎表明耐药性可能比以前认为的更为普遍,也对脆弱和其他易受感染的住院患者构成潜在威胁。